ConductScience.org, home

Paper32655804

Peroxiredoxin 4 promotes embryonal hepatoblastoma cell migration but induces fetal cell differentiation.

Zheng J and 14 others. Am J Transl Res, 2020. Cited by 7 papers, by iCite.

Cite this record

ConductScience Library. Peroxiredoxin 4 promotes embryonal hepatoblastoma cell migration but induces fetal cell differentiation. Papers, record 32655804. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/32655804

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Peroxiredoxin 4 promotes embryonal hepatoblastoma cell migration but induces fetal cell differentiation.
PubMed
Journal
Am J Transl Res
PubMed
Year
2020
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
7
iCite
Relative citation ratio, by iCite
0.32
iCite
Revised in PubMed
2020-09-28
PubMed

Authors15

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Zheng JJianbo
2Guo XXin
3Shioya AAkihiro
4Yoshioka TTakako
5Matsumoto KKimikazu
6Hiraki TTsubasa
7Kusano HHironori
8Oyama TTakeru
9Kurose NNozomu
10Yamaguchi RReimon
11Uramoto HHidetaka
12Ieiri SSatoshi
13Okajima HHideaki
14Kohno MMiyuki
15Yamada SSohsuke

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References47

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
130013444The Combination Of Weak Expression Of PRDX4 And Very High MIB-1 Labelling Index Independently Predicts Shorter Disease-free Survival In Stage I Lung Adenocarcinoma.Int J Med Sci2018https://conductscience.org/library/papers/30013444PubMed
211905674SIOPEL trials using preoperative chemotherapy in hepatoblastoma.Lancet Oncol2000https://conductscience.org/library/papers/11905674PubMed
312939582Epidemiology of primary hepatic malignancies in U.S. children.Hepatology2003https://conductscience.org/library/papers/12939582PubMed
419751877Hep G2 is a hepatoblastoma-derived cell line.Hum Pathol2009https://conductscience.org/library/papers/19751877PubMed
512586629Peroxiredoxin II is essential for sustaining life span of erythrocytes in mice.Blood2003https://conductscience.org/library/papers/12586629PubMed
621859152Identification of PRDX4 and P4HA2 as metastasis-associated proteins in oral cavity squamous cell carcinoma by comparative tissue proteomics of microdissected specimens using iTRAQ technology.J Proteome Res2011https://conductscience.org/library/papers/21859152PubMed
728923827Mutant CTNNB1 and histological heterogeneity define metabolic subtypes of hepatoblastoma.EMBO Mol Med2017https://conductscience.org/library/papers/28923827PubMed
821768450Complete surgical resection is curative for children with hepatoblastoma with pure fetal histology: a report from the Children's Oncology Group.J Clin Oncol2011https://conductscience.org/library/papers/21768450PubMed
914746860Risk-adapted treatment for childhood hepatoblastoma. final report of the second study of the International Society of Paediatric Oncology--SIOPEL 2.Eur J Cancer2004https://conductscience.org/library/papers/14746860PubMed
1023831416Dose-dense cisplatin-based chemotherapy and surgery for children with high-risk hepatoblastoma (SIOPEL-4): a prospective, single-arm, feasibility study.Lancet Oncol2013https://conductscience.org/library/papers/23831416PubMed
1125078725Mutational landscape of hepatoblastoma goes beyond the Wnt-β-catenin pathway.Hepatology2014https://conductscience.org/library/papers/25078725PubMed
1229687726The Association of Peroxiredoxin 4 with the Initiation and Progression of Hepatocellular Carcinoma.Antioxid Redox Signal2019https://conductscience.org/library/papers/29687726PubMed
134290059Hepatoblastoma and hepatocarcinoma in infancy and childhood. Report of 47 cases.Cancer1967https://conductscience.org/library/papers/4290059PubMed
1428535186FXR-Gankyrin axis is involved in development of pediatric liver cancer.Carcinogenesis2017https://conductscience.org/library/papers/28535186PubMed
1525656995Physiological and pathological views of peroxiredoxin 4.Free Radic Biol Med2015https://conductscience.org/library/papers/25656995PubMed
1628174264Hippo signaling promotes JNK-dependent cell migration.Proc Natl Acad Sci U S A2017https://conductscience.org/library/papers/28174264PubMed
1722692949The epidemiology of hepatoblastoma.Pediatr Blood Cancer2012https://conductscience.org/library/papers/22692949PubMed
187542025Liver tumors in neonates and very young infants: diagnostic pitfalls and therapeutic problems.Eur J Pediatr Surg1995https://conductscience.org/library/papers/7542025PubMed
1922916164Suppression of peroxiredoxin 4 in glioblastoma cells increases apoptosis and reduces tumor growth.PLoS One2012https://conductscience.org/library/papers/22916164PubMed
2029237274Peroxiredoxin Involvement in the Initiation and Progression of Human Cancer.Antioxid Redox Signal2018https://conductscience.org/library/papers/29237274PubMed

See all 47 referencesDownload CSV of references

Cited by4

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 7 citations.

PMIDTitleJournalYearIn PapersSource
39773476The immunohistochemical combination of low SGLT2 expression and high PRDX4 expression independently predicts shortened survival in patients undergoing surgical resection for hepatoblastoma.Diagn Pathol2025https://conductscience.org/library/papers/39773476PubMed
37787446
The combination of the low immunohistochemical expression of peroxiredoxin 4 and perilipin 2 predicts longer survival in pancreatic ductal adenocarcinoma with peroxiredoxin 4 possibly playing a main role.
Histol Histopathol2023https://conductscience.org/library/papers/37787446PubMed
34477212The differential expression of perilipin-2 in hepatoblastoma and its association with prognosis.Histol Histopathol2021https://conductscience.org/library/papers/34477212PubMed
33456675Overexpression of PRDX4 Modulates Tumor Microenvironment and Promotes Urethane-Induced Lung Tumorigenesis.Oxid Med Cell Longev2020https://conductscience.org/library/papers/33456675PubMed

Download CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
PRDX410549PubTator's text mininghttps://conductscience.org/library/genes/10549

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/32655804

GET https://conductscience.org/api/papers/v1/32655804/references?page=2